Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
Hans‐Christoph Diener(University of Birmingham), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Martina Brueckmann, Jaime Masjuán(Boehringer Ingelheim (Germany)), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Jerzy Krupiński(University Hospital Mútua de Terrassa), Shinichiro Uchiyama(International University of Health and Welfare), Geoffrey A. Donnan(The Royal Melbourne Hospital), J. Donald Easton(University of California, San Francisco), Byung‐Chul Lee(Hallym University), Claudia Grauer(Boehringer Ingelheim (Germany)), José M. Ferro(University of Lisbon), Bernd Kallmünzer(Universitätsklinikum Erlangen), Danilo Toni(Sapienza University of Rome), Jeffrey L. Saver(University of California, Los Angeles), Peter D. Schellinger(University Hospitals of the Ruhr-University of Bochum), Richard A. Bernstein(Northwestern University), Ralph L. Sacco(University of Miami), Martin Grond(Boehringer Ingelheim (Germany)), Jörg Kreuzer(Boehringer Ingelheim (Germany)), M. A. Chernyatina(Boehringer Ingelheim (Germany)), Lisa Cronin(Boehringer Ingelheim (Germany)), Miroslav Odinak(Boehringer Ingelheim (Germany)), Christopher B. Granger(Clinical Research Institute)
Cited by 809
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k